The Life Raft Group provides support, information, education, and innovative research aimed at patients with Gastrointestinal Stromal Tumor (GIST), a rare cancer. Through various initiatives, they increase access to treatments, educate patients, advocate for better healthcare, and empower a global community of GIST patients and their caregivers.
2002
82-0547746
$2.905 million
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
A gathering for GIST patients, caregivers, and advocates to share experiences and learn from experts.
A day dedicated to raising awareness about GIST and the importance of timely diagnosis and treatment.
A webinar discussing scientific updates relevant to GIST patients presented by leading experts.
November 25, 2024
Dr. Alcindor will discuss scientific updates relevant to GIST patients that were exhibited at the Connective Tissue Oncology Society (CTOS) conference.
Learn MoreOverall Score
63
68
/100
Program Expense Ratio
91.12%
20
/20
Program Revenue Growth
0.00%
2
/20
Leverage Ratio
0.08475
20
/20
Working Capital Ratio
1.386
12
/20
Fundraising Efficiency
0.6838
14
/20
Fiscal Year:2022
Source:Source: Self-reported by organization
Category | Amount | Percentage |
---|---|---|
Contributions, Gifts, and Grants | 1.314M | 94.07% |
Program Services | 0 | 0.00% |
Investment Income | 41.02K | 2.94% |
Sales of Non-Inventory Assets | 0 | 0.00% |
Other Notable Sources | 667 | 0.05% |
Total Revenue | 1.397M | 100.00% |
Health Associations
Gastroenterology HealthHealth Associations
Gastroenterology HealthHealth Associations
Gastroenterology HealthHealth Associations
Gastroenterology HealthHealth Associations
Gastroenterology Health